ppharmПедиатрическая фармакологияPediatric pharmacology1727-57762500-3089Издательство «ПедиатрЪ»10.15690/pf.v19i2.2398ppharm-2153Research ArticleОБЗОР ЛИТЕРАТУРЫREVIEWДерматологические проявления COVID-19 у детейCOVID-19 Dermatological Manifestations in Childrenhttps://orcid.org/0000-0002-6760-3119ИванчиковВ. В.IvanchikovVladislav V.

Иванчиков Владислав Владимирович.

Москва.

eLibrary SPIN: 1078-5850

MD.

Moscow.

eLibrary SPIN: 1078-5850

awdawd22@yandex.ruhttps://orcid.org/0000-0002-8232-8936АмбарчянЭ. Т.AmbarchyanEduard T.

Амбарчян Эдуард Тигранович - кандидат медицинских наук, заведующий отделением дерматологии НИИ педиатрии и охраны здоровья детей НКЦ №2 РНЦХ им. акад. Б.В. Петровского.

117593, Москва, Литовский бульвар, д. 1а.

тел.: 8 (915) 400-00-02

eLibrary SPIN: 4878-5562

MD, PhD.

1а Litovsky bulvar, 117593 Moscow.

tel.: +7 (915) 400-00-02

eLibrary SPIN: 4878-5562

edo_amb@mail.ruhttps://orcid.org/0000-0003-3003-9398КузьминоваА. Д.KuzminovaAnastasia D.

Кузьминова Анастасия Дмитриевна.

Москва.

eLibrary SPIN: 7014-2239

MD.

Moscow.

eLibrary SPIN: 7014-2239

kuzminova_derma@mail.ruНИИ педиатрии и охраны здоровья детей НКЦ №2 РНЦХ им. акад. Б.В. ПетровскогоРоссияResearch Institute of Pediatrics and Children's Health in Petrovsky National Research Centre of SurgeryRussian Federation202217052022192105114Copyright © Иванчиков В.В., Амбарчян Э.Т., Кузьминова А.Д., 20222022Иванчиков В.В., Амбарчян Э.Т., Кузьминова А.Д.Ivanchikov V.V., Ambarchyan E.T., Kuzminova A.D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pedpharma.ru/jour/article/view/2153

В представленной публикации описаны различные дерматологические проявления COVID-19, которые развивались у пациентов детского возраста, описана частота их встречаемости, а также особенности клинической картины. Отдельно рассмотрены высыпания по типу псевдоотморожений как наиболее специфичные среди детской популяции, перенесшей коронавирусную инфекцию. Также представлено описание кожных проявлений при мультисистемном воспалительном синдроме у детей, затронуты вопросы лабораторной диагностики.

This article describes various COVID-19 dermatological manifestations that can develop in children. Their incidence and clinical features are described. Chilblain-like lesions were considered as the most typical in children population after coronavirus infection. Description of skin manifestations in multisystem inflammatory syndrome in children is also presented, issues of laboratory diagnosis are covered as well.

COVID-19SARS-CoV-2псевдоотморожениясыпьдетимультисистемный воспалительный синдромCOVID-19SARS-CoV-2chilblain-like lesionsrashchildrenmultisystem inflammatory syndromeReferencesKabeerdoss J, Pilania RK, Karkhele R, et al. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatol Int. 2021;41(1):19-32. doi: https://doi.org/10.1007/s00296-020-04749-4Kabeerdoss J, Pilania RK, Karkhele R, et al. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatol Int. 2021;41(1):19-32. doi: https://doi.org/10.1007/s00296-020-04749-4Nuno-Gonzalez A, Martin-Carrillo P, Magaletsky K, et al. Prevalence of mucocutaneous manifestations in 666 patients with COVID-19 in a field hospital in Spain: oral and palmoplantar findings. Br J Dermatol. 2021;184(1):184-185. doi: https://doi.org/10.1111/bjd.19564Nuno-Gonzalez A, Martin-Carrillo P, Magaletsky K, et al. Prevalence of mucocutaneous manifestations in 666 patients with COVID-19 in a field hospital in Spain: oral and palmoplantar findings. Br J Dermatol. 2021;184(1):184-185. doi: https://doi.org/10.1111/bjd.19564Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. doi: https://doi.org/10.1056/NEJMoa2001017Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. doi: https://doi.org/10.1056/NEJMoa2001017Morris SB, Schwartz NG, Patel P, et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(40):1450-1456. doi: https://doi.org/10.15585/mmwr.mm6940e1Morris SB, Schwartz NG, Patel P, et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(40):1450-1456. doi: https://doi.org/10.15585/mmwr.mm6940e1Marzano AV, Cassano N, Genovese G, et al. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue. Br J Dermatol. 2020;183(3):431-442. doi: https://doi.org/10.1111/bjd.19264Marzano AV, Cassano N, Genovese G, et al. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue. Br J Dermatol. 2020;183(3):431-442. doi: https://doi.org/10.1111/bjd.19264Labe P, Ly A, Sin C, et al. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children. J Eur Acad Dermatol Venereol. 2020;34(10):e539-e541. doi: https://doi.org/10.1111/jdv.16666Labe P, Ly A, Sin C, et al. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children. J Eur Acad Dermatol Venereol. 2020;34(10):e539-e541. doi: https://doi.org/10.1111/jdv.16666Seque CA, Enokihara MMSES, Porro AM, et al. Skin manifestations associated with COVID-19. An Bras Dermatol. 2022;97(1):75-88. doi: https://doi.org/10.1016/j.abd.2021.08.002Seque CA, Enokihara MMSES, Porro AM, et al. Skin manifestations associated with COVID-19. An Bras Dermatol. 2022;97(1):75-88. doi: https://doi.org/10.1016/j.abd.2021.08.002Tan SW, Tam YC, Oh CC. Skin manifestations of COVID-19: A worldwide review. JAAD Int. 2021;2:119-133. doi: https://doi.org/10.1016/j.jdin.2020.12.003Tan SW, Tam YC, Oh CC. Skin manifestations of COVID-19: A worldwide review. JAAD Int. 2021;2:119-133. doi: https://doi.org/10.1016/j.jdin.2020.12.003COVID Symptom Study App (archive). In: British Association of Dermatologists. Available online: https://covidskinsigns.com. Accessed on April 17, 2022.COVID Symptom Study App (archive). In: British Association of Dermatologists. Available online: https://covidskinsigns.com. Accessed on April 17, 2022.Rocha KO, Zanuncio VV, Freitas BAC, et al. “COVID toes”: A meta-analysis of case and observational studies on clinical, histopathological, and laboratory findings. Pediatr Dermatol. 2021;38(5):1143-1149. doi: https://doi.org/10.1111/pde.14805Rocha KO, Zanuncio VV, Freitas BAC, et al. “COVID toes”: A meta-analysis of case and observational studies on clinical, histopathological, and laboratory findings. Pediatr Dermatol. 2021;38(5):1143-1149. doi: https://doi.org/10.1111/pde.14805Andina D, Noguera-Morel L, Bascuas-Arribas M, et al. Chilblains in children in the setting of COVID-19 pandemic. Pediatr Dermatol. 2020;37(3):406-411. doi: https://doi.org/10.1111/pde.14215Andina D, Noguera-Morel L, Bascuas-Arribas M, et al. Chilblains in children in the setting of COVID-19 pandemic. Pediatr Dermatol. 2020;37(3):406-411. doi: https://doi.org/10.1111/pde.14215Andina D, Belloni-Fortina A, Bodemer C, et al. Skin manifestations of COVID-19 in children: Part 1. Clin Exp Dermatol. 2021;46(3):444-450. doi: https://doi.org/10.1111/ced.14481Andina D, Belloni-Fortina A, Bodemer C, et al. Skin manifestations of COVID-19 in children: Part 1. Clin Exp Dermatol. 2021;46(3):444-450. doi: https://doi.org/10.1111/ced.14481Nemazee L, Elangasinghe V. A Case of ‘Long Covid Toes' with Associated Cryofibrinogenaemia. In: 20th ESPD Annular Meeting, May 12-14, 2021. On-Line Poster.Nemazee L, Elangasinghe V. A Case of ‘Long Covid Toes' with Associated Cryofibrinogenaemia. In: 20th ESPD Annular Meeting, May 12-14, 2021. On-Line Poster.Volpi S, Picco P, Caorsi R, et al. Type I interferonopathies in pediatric rheumatology. Pediatr Rheumatol Online J. 2016;14(1):35. doi: https://doi.org/10.1186/s12969-016-0094-4Volpi S, Picco P, Caorsi R, et al. Type I interferonopathies in pediatric rheumatology. Pediatr Rheumatol Online J. 2016;14(1):35. doi: https://doi.org/10.1186/s12969-016-0094-4Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res. 2020;220:1-13. doi: https://doi.org/10.1016/j.trsl.2020.04.007Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res. 2020;220:1-13. doi: https://doi.org/10.1016/j.trsl.2020.04.007Gianotti R, Recalcati S, Fantini F, et al. Histopathological Study of a Broad Spectrum of Skin Dermatoses in Patients Affected or Highly Suspected of Infectionby COVID-19intheNorthernPartof Italy: Analysis of the Many Faces of the Viral-Induced Skin Diseases in Previous and New Reported Cases. Am J Dermatopathol. 2020;42(8):564-570. doi: https://doi.org/10.1097/DAD.0000000000001707Gianotti R, Recalcati S, Fantini F, et al. Histopathological Study of a Broad Spectrum of Skin Dermatoses in Patients Affected or Highly Suspected of Infectionby COVID-19intheNorthernPartof Italy: Analysis of the Many Faces of the Viral-Induced Skin Diseases in Previous and New Reported Cases. Am J Dermatopathol. 2020;42(8):564-570. doi: https://doi.org/10.1097/DAD.0000000000001707Andina D, Belloni-Fortina A, Bodemer C, et al. Skin manifestations of COVID-19 in children: Part 2. Clin Exp Dermatol. 2021;46(3):451-461. doi: https://doi.org/10.1111/ced.14482Andina D, Belloni-Fortina A, Bodemer C, et al. Skin manifestations of COVID-19 in children: Part 2. Clin Exp Dermatol. 2021;46(3):451-461. doi: https://doi.org/10.1111/ced.14482Estebanez A, Perez-Santiago L, Silva E, et al. Cutaneous manifestations in COVID-19: a new contribution. J Eur Acad Dermatol Venereol. 2020;34(6):e250-e251. doi: https://doi.org/10.1111/jdv.16474Estebanez A, Perez-Santiago L, Silva E, et al. Cutaneous manifestations in COVID-19: a new contribution. J Eur Acad Dermatol Venereol. 2020;34(6):e250-e251. doi: https://doi.org/10.1111/jdv.16474Young S, Fernandez AP. Skin manifestations of COVID-19. Cleve Clin J Med. 2020 May 14. Online ahead of print. doi: https://doi.org/10.3949/ccjm.87a.ccc031Young S, Fernandez AP. Skin manifestations of COVID-19. Cleve Clin J Med. 2020 May 14. Online ahead of print. doi: https://doi.org/10.3949/ccjm.87a.ccc031Marzano AV, Genovese G, Fabbrocini G, et al. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: Multicenter case series of 22 patients. J Am Acad Dermatol. 2020;83(1):280-285. doi: https://doi.org/10.1016/j.jaad.2020.04.044Marzano AV, Genovese G, Fabbrocini G, et al. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: Multicenter case series of 22 patients. J Am Acad Dermatol. 2020;83(1):280-285. doi: https://doi.org/10.1016/j.jaad.2020.04.044Criado PR, Abdalla BMZ, de Assis IC, et al. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/ COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms. Inflamm Res. 2020;69(8):745-756. doi: https://doi.org/10.1007/s00011-020-01370-wCriado PR, Abdalla BMZ, de Assis IC, et al. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/ COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms. Inflamm Res. 2020;69(8):745-756. doi: https://doi.org/10.1007/s00011-020-01370-wde Masson A, Bouaziz JD, Sulimovic L, et al. Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France. J Am Acad Dermatol. 2020;83(2):667-670. doi: https://doi.org/10.1016/j.jaad.2020.04.161de Masson A, Bouaziz JD, Sulimovic L, et al. Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France. J Am Acad Dermatol. 2020;83(2):667-670. doi: https://doi.org/10.1016/j.jaad.2020.04.161Ventura-Espejo L, Gracia-Darder I, Escriba-Bori S, et al. Patient with H syndrome, cardiogenic shock, multiorgan infiltration, and digital ischemia. Pediatr Rheumatol Online J. 2021;19(1):104. doi: https://doi.org/10.1186/s12969-021-00586-2Ventura-Espejo L, Gracia-Darder I, Escriba-Bori S, et al. Patient with H syndrome, cardiogenic shock, multiorgan infiltration, and digital ischemia. Pediatr Rheumatol Online J. 2021;19(1):104. doi: https://doi.org/10.1186/s12969-021-00586-2Manalo IF, Smith MK, Cheeley J, et al. A dermatologic manifestation of COVID-19: transient livedoreticularis. J Am Acad Dermatol. 2020;83(2):700. doi: https://doi.org/10.1016/j.jaad.2020.04.018Manalo IF, Smith MK, Cheeley J, et al. A dermatologic manifestation of COVID-19: transient livedoreticularis. J Am Acad Dermatol. 2020;83(2):700. doi: https://doi.org/10.1016/j.jaad.2020.04.018Galeotti C, Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol. 2020;16(8):413-414. doi: https://doi.org/10.1038/s41584-020-0448-7Galeotti C, Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol. 2020;16(8):413-414. doi: https://doi.org/10.1038/s41584-020-0448-7Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771-1778. doi: https://doi.org/10.1016/S0140-6736(20)31103-XVerdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771-1778. doi: https://doi.org/10.1016/S0140-6736(20)31103-XYoung TK, Shaw KS, Shah JK, et al. Mucocutaneous Manifestations of Multisystem Inflammatory Syndrome in Children During the COVID-19 Pandemic. JAMA Dermatol. 2021;157(2):207-212. doi: https://doi.org/10.1001/jamadermatol.2020.4779Young TK, Shaw KS, Shah JK, et al. Mucocutaneous Manifestations of Multisystem Inflammatory Syndrome in Children During the COVID-19 Pandemic. JAMA Dermatol. 2021;157(2):207-212. doi: https://doi.org/10.1001/jamadermatol.2020.4779Naka F, Melnick L, Gorelik M, Morel KD. A dermatologic perspective on multisystem inflammatory syndrome in children. Clin Dermatol. 2021;39(1):163-168. doi: https://doi.org/10.1016/j.clindermatol.2020.09.003Naka F, Melnick L, Gorelik M, Morel KD. A dermatologic perspective on multisystem inflammatory syndrome in children. Clin Dermatol. 2021;39(1):163-168. doi: https://doi.org/10.1016/j.clindermatol.2020.09.003Miller J, Cantor A, Zachariah P, et al. Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children That Is Related to Coronavirus Disease 2019: A Single Center Experience of 44 Cases. Gastroenterology. 2020;159(4):1571-1574.e2. doi: https://doi.org/10.1053/j.gastro.2020.05.079Miller J, Cantor A, Zachariah P, et al. Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children That Is Related to Coronavirus Disease 2019: A Single Center Experience of 44 Cases. Gastroenterology. 2020;159(4):1571-1574.e2. doi: https://doi.org/10.1053/j.gastro.2020.05.079Andina D, Belloni-Fortina A, Bodemer C, et al. Skin manifestations of COVID-19 in children: Part 3. Clin Exp Dermatol. 2021;46(3):462-472. doi: https://doi.org/10.1111/ced.14483Andina D, Belloni-Fortina A, Bodemer C, et al. Skin manifestations of COVID-19 in children: Part 3. Clin Exp Dermatol. 2021;46(3):462-472. doi: https://doi.org/10.1111/ced.14483Salian VS, Wright JA, Vedell PT, et al. COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies. Mol Pharm. 2021;18(3):754-771. doi: https://doi.org/10.1021/acs.molpharmaceut.0c00608Salian VS, Wright JA, Vedell PT, et al. COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies. Mol Pharm. 2021;18(3):754-771. doi: https://doi.org/10.1021/acs.molpharmaceut.0c00608Centers for Disease Control and Prevention. Interim Guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) — Version 2.1. Available online: https://www.cdc.gov/coronavirus/mers/down-loads/Guidelines-Clinical-Specimens.pdf. Accessed on April 17, 2022.Centers for Disease Control and Prevention. Interim Guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) — Version 2.1. Available online: https://www.cdc.gov/coronavirus/mers/downloads/Guidelines-Clinical-Specimens.pdf. Accessed on April 17, 2022.Colonna C, Monzani NA, Rocchi A, et al. Chilblain-like lesions in children following suspected COVID-19 infection. Pediatr Dermatol. 2020;37(3):437-440. doi: https://doi.org/10.1111/pde.14210Colonna C, Monzani NA, Rocchi A, et al. Chilblain-like lesions in children following suspected COVID-19 infection. Pediatr Dermatol. 2020;37(3):437-440. doi: https://doi.org/10.1111/pde.14210Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017-1032. doi: https://doi.org/10.1038/s41591-020-0968-3Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017-1032. doi: https://doi.org/10.1038/s41591-020-0968-3Cazzato, G., Foti, C., Colagrande, A., et al. Skin Manifestation of SARS-CoV-2: The Italian Experience. J Clin Med. 2021;10(8):1566. doi: https://doi.org/10.3390/jcm10081566Cazzato, G., Foti, C., Colagrande, A., et al. Skin Manifestation of SARS-CoV-2: The Italian Experience. J Clin Med. 2021;10(8):1566. doi: https://doi.org/10.3390/jcm10081566Ahmed M, Advani S, Moreira A, et al. Multisystem inflammatory syndrome in children: A systematic review. EClinicalMedicine. 2020;26:100527. doi: https://doi.org/10.1016/j.eclinm.2020.100527Ahmed M, Advani S, Moreira A, et al. Multisystem inflammatory syndrome in children: A systematic review. EClinicalMedicine. 2020;26:100527. doi: https://doi.org/10.1016/j.eclinm.2020.100527

The authors declare that there are no conflicts of interest present.